Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease
- 1 October 1999
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 34 (4) , 669-677
- https://doi.org/10.1016/s0272-6386(99)70392-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Hyperhomocysteinemia as a Risk Factor for Cardiovascular Disease in Patients Undergoing HemodialysisPublished by Oxford University Press (OUP) ,2009
- Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Low Whole-Blood S -Adenosylmethionine and Correlation Between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- The effect of blood sample aging and food consumption on plasma total homocysteine levelsClinica Chimica Acta; International Journal of Clinical Chemistry, 1992
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular diseaseMetabolism, 1988
- Putative atherogenic factors in patients with chronic renal failureProgress in Cardiovascular Diseases, 1983